Can you make inflammation claims regarding joint health? How do you differentiate products in the bone health sector where so many products are based on calcium and vitamin D?
If you missed our live event Bone & Joint Health 2013 on July 24, don’t worry, all of the content is now available free - on-demand - for you to view at your leisure.
If you have already registered, but couldn't make it, or want to listen again, click here to access the on-demand webinars .
If you are not registered for the event, click here to register (it’s free), and then you will be able to access all the content .
To whet your appetite, here’s a quick breakdown of the topics we covered. All the presenters’ slides are also available for download under the ‘Resources’ section of the website.
Supporting joint health with anti-inflammatory nutrients
Dr Alexander Schauss, Senior Research Director, AIBMR Life Sciences, Inc., gives an intriguing presentation about inflammation and joint health. During the presentation, Dr Schauss answers key questions about this topic, including what considerations should a company consider in designing studies to evaluate the efficacy and safety of ingredients/products targeted to supporting joint health? What is the state of the science behind joint health ingredients? How do the regulators currently view the category? What criteria should you consider in evaluating ingredients/products for consideration?
Bone health – Differentiation in a generic marketplace
David Barnes, Director of Research, Standard Process Inc., delves into the topic of bone health formulations, with in-depth considerations about how to develop a bone health formulation to take on the generics. Dr Barnes’ discusses the science to support the ingredients that can complement and enhance formulations based on calcium and vitamin D.
Important Innovations in Vitamin K
Dr Egil Greve, CEO of Kappa Bioscience, discusses the bone health opportunities opening up in the vitamin K field. Greve explained why vitamin K2 MK-7 is essential for good bone health, and explains how intake deficiencies in Western markets must be addressed by supplements and food/beverage product manufacturers.
Exploring glucosamine’s potential mechanism of action in maintaining joint health
For joint health, glucosamine is the elephant in the room. However, the scientific evidence to support joint health benefits from oral glucosamine in a healthy population is limited. Dr. Kristine Clark, Ph.D., Director of Sports Nutrition for Penn State University, presents emerging preclinical research into the ingredients benefits, and is supported by Chuck Ray and Kristen Dammann from Cargill Corn Milling, who talk about the company’s Regenasure glucosamine ingredient.
Look beyond calcium. Introducing KoACT a superior bone solution
Jennifer Gu, Vice President Research & Development, AIDP discusses innovations in the calcium field, with a focus on AIDP’s KoACT ingredient. Gu presents data to support claims that KoACT builds stronger bones by shifting the bone metabolism to increased bone synthesis and reduced bone resorption.